Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis
07 nov. 2024 07h00 HE
|
Tilray Brands, Inc.
This trial aimed to test the effectiveness of an oral cannabis extract in adults suffering from negative chemotherapy-induced side effects.
Tilray Medical Announces New Scientific Publication on Age-Related Patterns of Medical Cannabis Use
03 avr. 2024 07h00 HE
|
Tilray Brands, Inc.
Tilray Medical announced a new Tilray led scientific publication, Age-related Patterns of medical Cannabis Use: A Survey of Authorized Patients in Canada.